ScholarWorks@Gyeongsang National University

Browsing by Ahn, Hee KyungAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 6 of 6

SCIESCOPUSKCI
A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapyopen access

Won, Young-Woong; Kang, Jin-Hyoung; Kwon, Jung Hye; Koo, Dong-Hoe; Kang, Jung Hun; Maeng, Chi Hoon; Ahn, Hee Kyung; Oh, Sung Yong; Lee, Dae-Won; Sohn, Joohyuk, et al.

ArticleIssue Date2023CitationCancer research and treatment, v.55, no.4, pp 1096 - 1103Publisher대한암학회
SCIESCOPUS
A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor-Induced Skin Toxicitiesopen access

Kim, Young Saing; Ji, Jun Ho; Oh, Sung Yong; Lee, Suee; Huh, Seok Jae; Lee, Ji Hyun; Song, Ki-Hoon; Son, Choon Hee; Roh, Mee Sook; Lee, Gyeong Won, et al.

ArticleIssue Date2020CitationONCOLOGIST, v.25, no.1, pp E186 - E193PublisherWILEY
SCIESCOPUSKCI
A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histologyopen access

Yi, Jun Ho; Kang, Jung Hun; Hwang, In Gyu; Ahn, Hee Kyung; Baek, Hyun Jin; Lee, Soon Il; Lim, Do Hyoung; Won, Young-Woong; Ji, Jun Ho; Kim, Hyo Song, et al.

ArticleIssue Date2016CitationCANCER RESEARCH AND TREATMENT, v.48, no.2, pp 553 - 560PublisherKOREAN CANCER ASSOCIATION
SCIESCOPUS
Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma (R)) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+metastatic breast cancer (KCSG BR 18-14/KM10B)open access

Sim, Sung Hoon; Kim, Jeong Eun; Kim, Min Hwan; Park, Yeon Hee; Kim, Jee Hyun; Suh, Koung Jin; Koh, Su-Jin; Park, Kyong Hwa; Kang, Myoung Joo; Ahn, Mi Sun, et al.

ArticleIssue Date2022CitationBreast, v.65, pp 172 - 178PublisherChurchill Livingstone
SCIESCOPUS
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer (TNBC) with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21).

Park, In Hae; Kim, Gun Min; Kim, Jee Hyun; Kim, Hanjo; Park, Kyong Hwa; Park, Yeon Hee; Baek, Sun Kyung; Sim, Sung Hoon; Ahn, Hee Kyung; Lee, Gyeong-Won, et al.

ArticleIssue Date2020CitationJournal of Clinical Oncology, v.38, no.15PublisherAmerican Society of Clinical Oncology
SCIESCOPUS
Retrospective analysis of extra-gastrointestinal stromal tumorsopen access

Yi, Jun Ho; Park, Byeong-Bae; Kang, Jung Hun; Hwang, In Gyu; Shin, Dong Bok; Sym, Sun Jin; Ahn, Hee Kyung; Lee, Soon Il; Lim, Do Hyoung; Park, Keon Woo, et al.

ArticleIssue Date2015CitationWORLD JOURNAL OF GASTROENTEROLOGY, v.21, no.6, pp 1845 - 1850PublisherBAISHIDENG PUBLISHING GROUP INC
1
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0533

COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어